Metabolic reprogramming of human CD8+ memory T cells through loss of SIRT1

Autor: Che-Ping Ng, Philip A. Hull, Mingjian Fei, Mark Y. Jeng, Hye-Sook Kwon, Nevan J. Krogan, Herb Kasler, Jeffrey R. Johnson, Melanie Ott, Eric Verdin, Chia-Lin Tsou, David E. Gordon
Rok vydání: 2018
Předmět:
0301 basic medicine
Granzyme B production
Cytotoxicity
Immunologic

endocrine system
Cytotoxicity
Immunology
chemical and pharmacologic phenomena
CD8-Positive T-Lymphocytes
Medical and Health Sciences
03 medical and health sciences
Sirtuin 1
CD28 Antigens
T-Lymphocyte Subsets
Immunologic
medicine
Immunology and Allergy
Cytotoxic T cell
Humans
2.1 Biological and endogenous factors
Aetiology
Research Articles
Regulation of gene expression
Chemistry
Forkhead Box Protein O1
Prevention
Brief Definitive Report
CD28
food and beverages
hemic and immune systems
3. Good health
Cell biology
030104 developmental biology
medicine.anatomical_structure
Gene Expression Regulation
lipids (amino acids
peptides
and proteins)

NAD+ kinase
Energy Metabolism
Memory T cell
Reprogramming
Immunologic Memory
CD8
hormones
hormone substitutes
and hormone antagonists

Biomarkers
Zdroj: The Journal of experimental medicine, vol 215, iss 1
The Journal of Experimental Medicine
Popis: The evolutionarily conserved SIRT1–FoxO1 axis plays a new role in human CD8+ T cell metabolism and function. Progression from the naive to the terminally differentiated memory state is accompanied by the loss of SIRT1 and FoxO1 expression, which derepresses glycolytic and cytotoxic capacities of CD8+CD28– T cells under resting conditions.
The expansion of CD8+CD28– T cells, a population of terminally differentiated memory T cells, is one of the most consistent immunological changes in humans during aging. CD8+CD28– T cells are highly cytotoxic, and their frequency is linked to many age-related diseases. As they do not accumulate in mice, many of the molecular mechanisms regulating their fate and function remain unclear. In this paper, we find that human CD8+CD28– T cells, under resting conditions, have an enhanced capacity to use glycolysis, a function linked to decreased expression of the NAD+-dependent protein deacetylase SIRT1. Global gene expression profiling identified the transcription factor FoxO1 as a SIRT1 target involved in transcriptional reprogramming of CD8+CD28– T cells. FoxO1 is proteasomally degraded in SIRT1-deficient CD8+CD28– T cells, and inhibiting its activity in resting CD8+CD28+ T cells enhanced glycolytic capacity and granzyme B production as in CD8+CD28– T cells. These data identify the evolutionarily conserved SIRT1–FoxO1 axis as a regulator of resting CD8+ memory T cell metabolism and activity in humans.
Databáze: OpenAIRE